| 标题 |
Effectiveness and cost-effectiveness of pembrolizumab in persistent, recurrent, or metastatic cervical cancer with PD-L1 CPS 1–10: secondary analysis of KEYNOTE-826 using innovative KMSubtraction |
| 网址 | |
| DOI | |
| 其它 |
期刊:Expert Review of Pharmacoeconomics & Outcomes Research 作者:Jin Zhou; Jiaqin Cai; Lirong Zhang; Yixiao Zhu; Li Lin; et al 出版日期:2026-06-18 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人或该文件上传人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)